Evidence map›Paper›PMID 22140479›Full record

ArticlePloS one2011

Potential tumor suppressor NESG1 as an unfavorable prognosis factor in nasopharyngeal carcinoma.

Zhen Liu, Weiren Luo, Ying Zhou, Yan Zhen, Huiling Yang, Xiaoli Yu, Yanfen Ye, Xin Li, Hao Wang, Qinping Jiang and 3 more

RetractedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Forkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin Signaling Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Decreased CCDC19 is correlated with unfavorable outcome in lung squamous cell carcinoma.International journal of clinical and experimental pathology · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Zhen LiuDepartment of Pathology, Basic School of Guangzhou Medical College, Guangzhou, People's Republic of China.
Weiren Luo
Ying Zhou
Yan Zhen
Huiling Yang
Xiaoli Yu
Yanfen Ye
Xin Li
Hao Wang
Qinping Jiang
Yajie Zhang
Kaitai Yao
Weiyi Fang
Southern Medical University · CNGuangdong Medical College · CNGuangzhou Medical University · CNThird Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently we identified nasopharyngeal epithelium specific protein 1 (NESG1) as a potential tumor suppressor in nasopharyngeal carcinoma (NPC). The purpose of this study is to investigate the involvement of NESG1 in tumor progression and prognosis of human NPC. METHODOLOGY/PRINCIPAL

findingsNESG1 protein expression in NPC was examined. Survival analysis was performed using Kaplan-Meier method. The effect of NESG1 on cell proliferation, migration, and invasion were also investigated.

resultsNESG1 expression was downregulated in atypical hyperplasia and NPC samples compared to normal and squamous nasopharynx tissues. Reduced protein expression was negatively associated with the status of NPC progression. Patients with lower NESG1 expression had a shorter overall survival and disease-free time than did patients with higher NESG1 expression. Multivariate analysis suggested NESG1 expression as an independent prognostic indicator for NPC patient survival. Proliferation, migration, and invasion ability were significantly increased in cell lines following lentiviral-mediated shRNA suppression of NESG1 expression. Microarray analysis indicated that NESG1 participated in multiple pathways, including MAPK signaling and cell cycle regulation. Finally, DNA methylation microarray examination revealed a lack of hypermethylation at the NESG1 promoter, suggesting other mechanisms are involved in suppressing NESG1 expression in NPC.

conclusionOur studies are the first to demonstrate that decreased NESG1 expression is an unfavorable prognostic factor for NPC.

Indexed as

AgedCarcinomaCell MovementCell ProliferationCyclin A1Cyclin-Dependent Kinase Inhibitor p21Cytoskeletal ProteinsDisease-Free SurvivalDisease ProgressionDNA MethylationDown-RegulationFemaleGene Expression Regulation, NeoplasticHumansHyperplasiaMaleCCNA1 protein, humanCFAP45 protein, humanCyclin A1Cyclin-Dependent Kinase Inhibitor p21Cytoskeletal ProteinsProteins

Identifiers

PMID22140479
PMCPMC3225374
OpenAlexW2052829431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.